Nov 07, 2019 / 01:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Q3 2019 Pacira Biosciences Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Susan Mesco, Head of Investor Relations.
Susan Mesco - Pacira BioSciences, Inc. - Head of IR
Thank you, Whitney, and good morning, everyone. Welcome to today's conference call to discuss our third quarter 2019 financial results. Joining me on today's call are Dave Stack, Chief Executive Officer; Dr. Richard Scranton, Chief Medical Officer; and Charlie Reinhart, Chief Financial Officer.
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties. Please refer to our filings with the SEC, which are available from the SEC or our website for information concerning the risk factors that could affect the company. With that, I will now turn the call over to Dave
Q3 2019 Pacira Biosciences Inc Earnings Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers